eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3-4/2006
vol. 31
 
Share:
Share:
abstract:

Clinical immunology
Immunomodulatory effect of recombinant human procalcitonin on mitogenic activity of lymphocytes

Mária Bucová
,
Roman Záhorec
,
Milan Buc

Centr Eur J Immunol 2006; 31 (3-4): 87-93
Online publish date: 2007/01/16
View full text Get citation
 
Procalcitonin (PCT) is an excellent inflammatory marker for early diagnosis of sepsis. However, little is known about its immunological functions.

Objective: The aim of our work was to determine the effect of recombinant human (rh) PCT on blastic transformation of lymphocytes.

Methods: Peripheral blood lymphocytes from 9 healthy volunteers were isolated on Ficoll-Metrizoat gradient and cultivated with polyclonal mitogens phytohemaglutinin (PHA), concanavalin A (Con A) and lipopolysaccharide (LPS) with or without rhPCT. RhPCT was added to the cultures in four different final concentrations.

Results: 1. RhPCT significantly inhibited the blastic transformation of PHA activated T-lymphocytes
(by 14-26%) as well as the simultaneous activation of T cells with rhPCT and PHA (21%). 2. RhPCT significantly decreased the ability of T cells stimulated by Con A either simultaneously (13-19%)
or subsequently (21-41%). 3. RhPCT increased the activity of unstimulated autologous lymphocytes.

Conclusion: Our preliminary results indicate that rhPCT suppressed the activity of both PHA and Con A stimulated T-cells, however it increased the activity of unstimulated lymphocytes. The results indicate that in vivo production of PCT in septic patients might contribute to a suppression of the hyperactivated specific cellular immunity.
keywords:

immunity, lymphocytes, mitogens, procalcitonin, sepsis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.